Alternatives to Eli Lilly and Company

Biopharmaceutical company focused on rare genetic diseases of obesity.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Global biotechnology company pioneering innovative medicines for complex neurological, neuropsychiatric, and rare diseases.

Global healthcare company focused on diabetes care, obesity, and rare blood disorders.

A global pharmaceutical and biotechnology corporation developing innovative medicines and vaccines for various therapeutic areas.

A global oncology company developing and commercializing innovative cancer treatments.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Leveraging the adaptive immune system to diagnose and treat disease.

Developing engineered biologics to harness the immune system for disease treatment.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.